Diversity Plans: Are you ready?
Diversity Plans: Are you ready? It is widely discussed that the clinical trial industry suffers from a lack of diversity in clinical trial outcomes. “Diversity” represents a wide-range of descriptions,…
M&B Sciences Inc Acquires Clara Health and Announces Goal to Become a Leader in Patient Recruitment and Retention in Clinical Trials
March 09, 2022 09:29 AM Eastern Standard Time SAN DIEGO, Calif.–(BUSINESS WIRE)–M&B Sciences Inc, a fast-growing African-American owned, technology-driven clinical research organization, announces the acquisition of Clara Health, a company…
IMPORTANCE OF DIVERSE POPULATIONS IN CLINICAL TRIALS
Clinical trials are a vital stage in the development of any drug for market. However, they can have weaknesses, and a common one is the demographic makeup of the trial…
Q&A WITH DR. EDDILISA MARTIN: WHY REPRESENTATION MATTERS IN CLINICAL TRIALS
After researchers examined demographic characteristics of 230 US-based clinical trials from July 2011 through June 2020, they found startling results. Among the 219,555 clinical trial participants, White individuals were overrepresented…
WHAT IS DIVERSITY IN CLINICAL TRIALS?
Clinical trials play an essential role in achieving positive health outcomes for patients of every race, gender, sex, age, geography and socioeconomic status. With that realization, a growing number of…
WHAT ROLE CAN TECHNOLOGY PLAY IN BRINGING TRIALS DIRECTLY TO PATIENTS?
Clinical trials can and should be available to a broad and representative population, not restricted by geography, ethnicity, socioeconomic status, or gender. Technology can play an important role in circumventing…